The American Journal of Digestive Diseases

, Volume 8, Issue 11, pp 437–439 | Cite as

Toxicity Studies on Stilbestrol

  • A. H. Aaron
  • Frank Meyers
  • Morton H. Lipsitz
  • Roger S. Hubbard


Thirty patients with chronic arthritis were treated with maximum doses of stilbestrol (1–3 mg. daily for periods ranging from five to nine weeks, receiving amounts varying from 55 to 189 mg.). The outstanding clinical observation was a marked improvement in general well-being in eighty per cent of the group. Nausea occurred in fifty per cent but was controlled by reduction of dosage and in no instance was it necessary to discontinue treatment because of this complaint.

An analysis of the results of liver function tests both before and after treatment with stilbestrol (bilirubin excretion, hippuric acid excretion, icterus index, van den Bergh, cholesterol, and cholesterol esters partition) showed no evidence of liver damage. There was no significant change in the blood count, urinalysis, blood urea and blood glucose after stilbestrol therapy.


Galactose Liver Function Test Hippuric Acid Chronic Arthritis Rose Bengal 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hench, P. S.: Amelioration of Pregnancy on Chronic Atrophic Arthritis, Fibrositis and Intermittent Hydro-arthrosis. Proc. Staff Meet. Mayo Clinic, Vol. 13, pp. 161–167, 1938.Google Scholar
  2. 2.
    Hall, F. C.: Menopausal Arthralgia—Study of Seventy-one Women at Artificial Menopause.New England J. Med., Vol. 219, pp. 1015–1026, 1938.Google Scholar
  3. 3.
    Osgood, R. B.: Medical and Social Approaches to the Problem of Chronic Rheumatism.Am. J. Med. Sci., Vol. 200, pp. 429–444, Oct., 1940.CrossRefGoogle Scholar
  4. 4.
    Cohen, A., Dubbs, A. W. and Meyers, A.: The Treatment of Atrophie Arthritis with Estrogenic Substances.New England J. Med., Vol. 222, pp. 140, Jan. 25, 1940.CrossRefGoogle Scholar
  5. 5.
    Dunn, C. W.: Endocrine Treatment in Arthritis.Med. Clinics of North America, Vol. 24, pp. 1697–1708, Nov., 1940.Google Scholar
  6. 6.
    Woodhead: Quoted by Dunn.Google Scholar
  7. 7.
    Selye, H.: On the Toxicity of Estrogens with Special References to Diethylstilbestrol.Canadian Med. Ass’n. J., Vol. 41, pp. 48–49, July, 1939.Google Scholar
  8. 8.
    Von Haam, E., Hammel, M. A., Rardin, T. E. and Schoene, R. H.: Experimental Studies on the Activity and Toxicity of Stilbestrol.Endocrinology, Vol. 28, pp. 263–273, Feb., 1941.Google Scholar
  9. 9.
    Mazer, Charles, Israel, S. L. and Ravetz, E.: The Synthetic Estrogen Stilbestrol.J. A. M. A., Vol. 116, pp. 675–681, Feb. 22, 1941.Google Scholar
  10. 10.
    Tislowitz, R.: Toxic Action of Large Doses of Diethylstilbestrol on the Blood in Dogs.Acta Brevia Neerland, Physiol. Pharm. Microbiol., Vol. 9, No. 1, pp. 15–17, 1939.Google Scholar
  11. 11.
    Arnold, O.: Action of Stilbestrol on Blood of Dogs.Klin. Wchnschr., Vol. 18, pp. 891–892, June 24, 1939.CrossRefGoogle Scholar
  12. 12.
    MacBryde, C. M., Castrodale, D., Helwig, E. B., Bierbaum, O. and Poes, J. H.: Effects of Synthetic and Natural Estrogens on Blood Liver and Bone Marrow. Abstract of Proceedings ofAm. J. Clin. Invest., inJ. Clin. Invest., Vol. 19, pp. 773, Sept., 1940.Google Scholar
  13. 13.
    Mac Bryde, C. M., Freedman, J. H. and Loeffel, E.: Studies on Stilbestrol Preliminary Statement.J. A. M. A., Vol. 113, pp. 2320, Dec. 23, 1939.Google Scholar
  14. 14.
    Shorr, E., Robinson, H. and Papanicolaou, G. N.: A Clinical Study of the Synthetic Estrogen Stilbestrol.J. A. M. A., Vol. 113, pp. 2312, 2318, Dec. 23, 1939.Google Scholar
  15. 15.
    Collins, C. G., Weed, J. C. Weinstein, B. and Lock, F. R.: Clinical Experiences with Stilbestrol.Am. J. Obst. and Gyn., Vol. 39, pp. 117–121, Jan., 1940.Google Scholar
  16. 16.
    Kurzrok, R., Wilson, L. and Perloff, W. H.: The Action of Diethylstilbestrol in Gynecological Dysfunctions.Endocrinol., Vol. 26, pp. 581–586, April, 1940.CrossRefGoogle Scholar
  17. 17.
    Huberman, J. and Colmer, M. J.: The Effects of Stilbestrol on Menopausal Symptoms.Am. J. Obst. and Gyn., Vol. 39, pp. 783–791, May, 1940.Google Scholar
  18. 18.
    Peters, J. P. and Van Slyke, D. D.: Quantitative Clinical Chemistry. Vol. 11, Methods, pp. 504–506. Williams & Wilkins, Balto, 1932.Google Scholar
  19. 19.
    Quick, A. J.: Clinical Value of Test for Hippuric Acid in Cases of Diseases of Liver.Arch. Int. Med., Vol. 57, pp. 544–556, March, 1936.Google Scholar
  20. 20.
    Filbott, W.:Ztschr. f. Klin. Med., 1927, cvi, 529 Funklionsprufung der, Leber Mittels Bilirubinbelestung (mit 7 Textabbuldungen).Google Scholar
  21. 21.
    Mac Bryde, C. M., Freedman, H., Loeffel, E. and Allen, D.: Estrogenic Treatment by Implanation of Stilbestrol Pellets.Proc. Soc. Exper. Biol. and Med., Vol. 43, pp. 212–214, Jan., 1940.Google Scholar
  22. 22.
    Heilbrun, N. and Hubbard, R. S.: The Measurement of the Chloroform Soluble Fraction of Bilirubin in Persons with Jaundice and Its Significance.J. Lab. and Clin. Med., Vol. 26, p. 576, Dec., 1940.Google Scholar

Copyright information

© Springer 1941

Authors and Affiliations

  • A. H. Aaron
    • 1
  • Frank Meyers
    • 1
  • Morton H. Lipsitz
    • 1
  • Roger S. Hubbard
    • 1
  1. 1.Buffalo

Personalised recommendations